124 related articles for article (PubMed ID: 36269441)
21. Intravitreal Sustained-Release Steroid Implants for the Treatment of Macular Edema following Surgical Removal of Epiretinal Membranes.
Hattenbach LO; Springer-Wanner C; Hoerauf H; Callizo J; Jungmann S; Brauns T; Fulle G; Eichel S; Koss MJ; Kuhli-Hattenbach C
Ophthalmologica; 2017; 237(4):232-237. PubMed ID: 28463851
[TBL] [Abstract][Full Text] [Related]
22. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
Ahn SJ; Kim KE; Woo SJ; Park KH
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
[TBL] [Abstract][Full Text] [Related]
23. Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant.
Shi K; Sun X; Zhang J
Dis Markers; 2021; 2021():3510036. PubMed ID: 34691285
[TBL] [Abstract][Full Text] [Related]
24. MULTIMODAL IMAGING OF RECURRENT CYSTOID MACULAR EDEMA ASSOCIATED WITH POEMS SYNDROME RESPONSIVE TO INTRAVITREAL DEXAMETHASONE IMPLANT.
Pole C; Hosseini H; Prasad P
Retin Cases Brief Rep; 2022 Sep; 16(5):565-568. PubMed ID: 32969981
[TBL] [Abstract][Full Text] [Related]
25. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal dexamethasone implant for recalcitrant cystoid macular edema secondary to retinitis pigmentosa: a pilot study.
Sudhalkar A; Kodjikian L; Borse N
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1369-1374. PubMed ID: 28378252
[TBL] [Abstract][Full Text] [Related]
27. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.
Blanc J; Deschasse C; Kodjikian L; Dot C; Bron AM; Creuzot-Garcher C
Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1441-1448. PubMed ID: 29855706
[TBL] [Abstract][Full Text] [Related]
28. DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF RECALCITRANT MACULAR EDEMA AFTER RHEGMATOGENOUS RETINAL DETACHMENT REPAIR.
Thanos A; Todorich B; Yonekawa Y; Papakostas TD; Khundkar T; Eliott D; Dass AB; Williams GA; Capone A; Faia LJ; Wolfe JD; Hassan TS; Ruby AJ
Retina; 2018 Jun; 38(6):1084-1090. PubMed ID: 28622270
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Effectiveness of Treatment with Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion.
Donati S; Gandolfi C; Caprani SM; Cattaneo J; Premoli L; Azzolini C
Biomed Res Int; 2018; 2018():3095961. PubMed ID: 30175123
[TBL] [Abstract][Full Text] [Related]
30. Short-term outcomes of intravitreal dexamethasone in relation to biomarkers in diabetic macular edema.
Narnaware SH; Bawankule PK; Raje D
Eur J Ophthalmol; 2021 May; 31(3):1185-1191. PubMed ID: 32429696
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Macular Edema after Pars Plana Vitrectomy for Idiopathic Epiretinal Membrane Using Intravitreal Dexamethasone Implant: Long-Term Outcomes.
Chatziralli I; Dimitriou E; Theodossiadis G; Chatzirallis A; Kazantzis D; Theodossiadis P
Ophthalmologica; 2019; 242(1):16-21. PubMed ID: 30889589
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of intravitreal dexamethasone implants in macular edema excluding venous occlusions: results for a cohort of 80 patients].
Degoumois A; Akesbi J; Laurens C; Rodallec FT; Adam R; Blumen-Ohana E; Laplace O; Virevialle C; Le Dû B; Guyader V; Nordmann JP
J Fr Ophtalmol; 2015 Feb; 38(2):126-33. PubMed ID: 25592383
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal Fluocinolone Acetonide (ILUVIEN) Implant for the Treatment of Refractory Cystoid Macular Oedema After Retinal Detachment Repair.
Alfaqawi F; Sarmad A; Ayesh K; Mitra A; Sharma A
Turk J Ophthalmol; 2018 Jun; 48(3):155-157. PubMed ID: 29988755
[TBL] [Abstract][Full Text] [Related]
34. Retraction of cystoid macular edema from the fovea after intravitreal anti-VEGF therapy for birdshot chorioretinopathy.
Ba-Ali S; Fuchs J; Larsen M
Retin Cases Brief Rep; 2023 Oct; ():. PubMed ID: 37874763
[TBL] [Abstract][Full Text] [Related]
35. Cystoid Macular Edema after Complicated Cataract Surgery Resolved by an Intravitreal Dexamethasone 0.7-mg Implant.
Meyer LM; Schönfeld CL
Case Rep Ophthalmol; 2011 Sep; 2(3):319-22. PubMed ID: 22125533
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion.
Şekeroğlu MA; Taşkale FB; Doğuizi S; Yılmazbaş P
Turk J Ophthalmol; 2022 Aug; 52(4):276-280. PubMed ID: 36017487
[TBL] [Abstract][Full Text] [Related]
37. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
[TBL] [Abstract][Full Text] [Related]
38. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
39. Migration of intravitreal dexamethasone implant to anterior chamber.
Gullapalli VK; DiLoreto DA
Retin Cases Brief Rep; 2013; 7(1):111-3. PubMed ID: 25390539
[TBL] [Abstract][Full Text] [Related]
40. INTRAVITREAL DEXAMETHASONE IMPLANT IN RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA.
Mansour AM; Sheheitli H; Kucukerdonmez C; Sisk RA; Moura R; Moschos MM; Lima LH; Al-Shaar L; Arevalo JF; Maia M; Foster RE; Kayikcioglu O; Kozak I; Kurup S; Zegarra H; Gallego-Pinazo R; Hamam RN; Bejjani RA; Cinar E; Erakgün ET; Kimura A; Teixeira A
Retina; 2018 Feb; 38(2):416-423. PubMed ID: 28221257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
